These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 18937637)

  • 1. Systemic vasculitis treatment and monitoring update, 2008.
    Yazici Y
    Bull NYU Hosp Jt Dis; 2008; 66(3):228-30. PubMed ID: 18937637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on vasculitis.
    Khasnis A; Langford CA
    J Allergy Clin Immunol; 2009 Jun; 123(6):1226-36. PubMed ID: 19501230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based management of ANCA vasculitis.
    Carruthers D; Sherlock J
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):367-78. PubMed ID: 19508944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CARI guidelines. Induction and maintenance therapy in ANCA-associated systemic vasculitis.
    Menahem S; Hiremagalur B; Mudge D; Toussaint N; Walters G;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S24-36. PubMed ID: 18713121
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of refractory and/or severe ANCA-associated systemic necrotizing vasculitides.
    Guillevin L; Pagnoux C
    Isr Med Assoc J; 2008 Jan; 10(1):89-91. PubMed ID: 18300585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EULAR recommendations for the management of primary small and medium vessel vasculitis.
    Mukhtyar C; Guillevin L; Cid MC; Dasgupta B; de Groot K; Gross W; Hauser T; Hellmich B; Jayne D; Kallenberg CG; Merkel PA; Raspe H; Salvarani C; Scott DG; Stegeman C; Watts R; Westman K; Witter J; Yazici H; Luqmani R;
    Ann Rheum Dis; 2009 Mar; 68(3):310-7. PubMed ID: 18413444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of ANCA-associated systemic vasculitis.
    Belmont HM
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):60-6. PubMed ID: 17121492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
    Flossmann O; de Groot K
    Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358
    [No Abstract]   [Full Text] [Related]  

  • 9. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
    Lapraik C; Watts R; Bacon P; Carruthers D; Chakravarty K; D'Cruz D; Guillevin L; Harper L; Jayne D; Luqmani R; Mooney J; Scott D;
    Rheumatology (Oxford); 2007 Oct; 46(10):1615-6. PubMed ID: 17804455
    [No Abstract]   [Full Text] [Related]  

  • 10. [Churg-Strauss syndrome--recent developments in diagnosis and treatment].
    Hellmich B; Metzler C; Gross WL
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2270-4. PubMed ID: 17036268
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic vasculitis: still a challenging disease.
    Buhaescu I; Covic A; Levy J
    Am J Kidney Dis; 2005 Aug; 46(2):173-85. PubMed ID: 16112036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous vasculitis: diagnosis and management.
    Carlson JA; Cavaliere LF; Grant-Kels JM
    Clin Dermatol; 2006; 24(5):414-29. PubMed ID: 16966021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis und therapy of ANCA-associated vasculitis].
    Aries PM; Hellmich B; Gross WL
    Dtsch Med Wochenschr; 2006 Mar; 131(9):443-6. PubMed ID: 16493569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Sanders JS; Slot MC; Stegeman CA
    N Engl J Med; 2003 Nov; 349(21):2072-3; author reply 2072-3. PubMed ID: 14627795
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimizing the therapeutic strategies in ANCA-associated vasculitis--single centre experience with international randomized trials.
    Vanková Z; Ríhová Z; Jancová E; Rysavá R; Merta M; Tesar V
    Prague Med Rep; 2006; 107(2):199-212. PubMed ID: 17066740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Tervaert JW; Stegeman CA; Kallenberg CG
    Curr Opin Nephrol Hypertens; 2001 Mar; 10(2):211-7. PubMed ID: 11224696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Part 3: Newer therapies for ANCA-associated vasculitis.
    Jayne D
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S77-9. PubMed ID: 17428377
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies.
    Goek ON; Stone JH
    Curr Opin Rheumatol; 2005 May; 17(3):257-64. PubMed ID: 15838233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies for systemic necrotizing vasculitides.
    Guillevin L; Pagnoux C
    Allergol Int; 2007 Jun; 56(2):105-11. PubMed ID: 17460440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CARI guidelines. ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis.
    Luxton G; Langham R;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S17-23. PubMed ID: 18713120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.